Evaluation of antioxidant potential of smilax zeylanica linn. in reversing haloperidol induced catalepsy in rats

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL.3, 2012, Pages 323-327

  Rasheed Ahemad, S ^a   Venkataraman, S ^b   Mohammed, Fazil Ahmed ^a   Jayveera, K N ^c  

^a Nizam Institute of Pharmacy   (India)

^b C L BAID METHA COLLEGE OF PHARMACY   (India)

^c JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Antioxidant; Haloperidol and Catalepsy; Smilax zeylanica

Indexed keywords

ALCOHOL; BRAIN ENZYME; CARBIDOPA PLUS LEVODOPA; CATALASE; GLUTATHIONE; HALOPERIDOL; PLANT EXTRACT; SMILAX ZEYLANICA EXTRACT; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN LEVEL; CATALEPSY; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG ISOLATION; DRUG SCREENING; MALE; NONHUMAN; OXIDATIVE STRESS; PLANT ROOT; RAT; SARSAPARILLA; SCORING SYSTEM;

EID: 84862612228     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: Relation to extra-pyramidal side effects. Arch Gen Psychiatry.1992; 49: 538-544.
2. Anden NE, Grabowska M. Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur J Pharmacol.1976; 39: 275-282.
3. Snoddy AM, Tessel RE. Effect on psychomotor stimulant cues and locomotor activity in mice. Eur J Pharmacol. 1985; 116: 221-228.
4. Sanberg PR. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature. 1980; 284: 472-473.
5. Sagara Y. Induction of reactive oxygen species in neurons by haloperidol. J Neurochem. 1998; 71:1002-1012.
6. Kedar NP. Can we prevent Parkinson's and Alzheimer's disease? J Postgrad Med. 2003; 49: 236-245.
7. Albina Arjuman, Vinod Nair, Gopalkrishna HN, Nandini M. Evaluation of the antioxidant potential of NR-ANX-C (a polyherbal formulation) and its individual constituents in reversing haloperidol induced catalepsy in mice. Indian J Pharmacol. 2007; 39(3):151-154.
8. rd ed. Bombay: Popular Prakashan; 1976.
9. Anisuzzaman M, Rahman AHMM, Harun-or-Rashid M, Naderuzzaman ATM and Islam AKMR. An Ethno botanical Study of Mdahupur, Tangail. J Applied Sciences Research. 2007; 3(7): 519-530.
10. Arun vijayan, Liju VB, Reena John JV, Parthipan B and Renekac. Traditional Remedies of kani tribes of kotor reserve forest, Agasthyavanam, Thiruvanathapuram Kerala. Indian J Traditional Knowledge. 2007; 6 (4): 589-594.
11. Sharma PV. Dravya Guna Vijnana. vol 2. Varanasi: Chaukamba bharathi Academy; 2005.
12. Yoganarasimhan, SN. Medicinal plants of India. Bangalore: Interline Publishing Pvt. Ltd; 2002.
13. th ed. Bombay: KM Varghese Co; 1988.
14. Madhavan V, Hemalatha, HT, Gurudeva MR and Yoganarasimhan SN. Indian J Nat Prod Res.2010; 3:328-337.
15. Madhavan V, Hemalatha HT, Anita M and Yoganarasimhan SN. Antiepileptic activity of alcohol and aqueous extracts of roots and rhizomes of Smilax zeylanica Linn. Pharmacologyonline. 2008; 3:263-272.
16. nd ed. New York (NY): CRC Press; 1997.
17. Chopde CT, Khisti RT, Mandane SN. Haloperidol-induced catalepsy: A model for screening antidepressants effective in treatment of depression with Parkinson's diseases. Indian J Exp Biol. 1997; 35:1297-1301.
18. Niehaus WG, Samuelson B. Formation of malondialdehyde from phospholipids arachidonate during microsomal lipid peroxidation. Eur J Biochem. 1968; 6:126-130.
19. Sinha KA. Colorimetric assay of catalase. Anal Biochem.1972; 47:389-394.
20. Beauchamp C, Fridovich I. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem. 1971; 44: 276-87.
21. Peterson GL. Review of the folin phenol protein quantification method of Lowry, Rosenbrough, Farr and Randall. Anal Biochem. 1979; 100:201-220.
22. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82:70-77.
23. Skaper SD, Floreani M, Ceccon M, Facci L and Giusti P. Excitotoxicity, oxidative stress and the neuroprotective potential of melatonin. Ann NY Acad Sci. 1999; 890:107-118.
24. Gilgun-Sherki Y, Rosenbaum Z, Melamed E and Offen D. Antioxidant therapy in acute central nervous system injury: the current state. Pharmacol Rev.2002; 54:271-284.
25. Naidu PS, Singh A and Kulkarni SK. Effect of Withania somnifera root extract on haloperidol induced orofacial dyskinesia: Possible mechanism of action. J Med Food. 2003; 6:107-114.
26. Aragno M, Brignardello E, Tamagno O and Boccuzzi G. Dehydroeppiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats. J Endocrinol. 1997; 155: 233-240.
27. Ahmad M, Yousuf S and Khan BM. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical, and Immunohistochemical studies. Pharmacol Biochem Behav. 2006; 83:150-160.
28. Gallistel CR, Davis AJ. Affinity for the dopamine D2 receptors predicts neuroleptic potency. Pharmacol Biochem Behav. 1983; 19:867-872.
29. Garris PA. A role for presynaptic mechanisms in the actions of Nomifensine and haloperidol. Neuroscience. 2003; 188:818-829.